23Na-MRI检测系统性硬化症纤维化皮肤中的钠沉积
该观察性病例对照研究用23Na-MRI定量12例弥漫性皮肤型SSc患者和21例对照者的皮肤钠含量,发现SSc纤维化皮肤钠升高,且皮肤钠与12个月后改良Rodnan皮肤评分变化相关(R²=0.68),提示23Na-MRI可能用于评估皮肤纤维化进展。
要点
- SSc纤维化皮肤钠含量高于对照皮肤(27.2 vs 21.4 mmol/l,P<0.01)。
- SSc纤维化皮肤钠含量高于非纤维化皮肤(26.2 vs 19.2 mmol/l,P<0.01)。
- 皮肤钠与随访12个月改良Rodnan皮肤评分变化相关(R²=0.68)。
核心结论
- 23Na-MRI检测到SSc纤维化皮肤中钠升高,高钠含量与皮肤病变进展相关。
- 23Na-MRI可能是评估皮肤钠并预测SSc皮肤纤维化进展的潜在工具。
研究设计与样本
- 观察性病例对照研究,纳入12例弥漫性皮肤型SSc患者和21例对照者。
- 用23Na-MRI及Na+容积线圈测定皮肤钠,基线和12个月后评估改良Rodnan皮肤评分。
主要发现
- SSc纤维化皮肤钠高于对照皮肤[均值(s.d.):27.2(5.6)vs 21.4(5.3)mmol/l,P<0.01]。
- SSc纤维化皮肤钠高于非纤维化SSc皮肤[26.2(4.8)vs 19.2(3.4)mmol/l,P<0.01]。
- 皮肤钠与随访改良Rodnan皮肤评分变化相关(R²=0.68)。
临床怎么用
- 对弥漫性皮肤型SSc患者,可考虑用23Na-MRI定量皮肤钠以辅助评估纤维化活动度。
- 皮肤钠较高者可能提示皮肤纤维化进展风险,需加强皮肤评分随访。
局限性
- 样本量小(12例SSc、21例对照),为观察性病例对照研究。
- 结论基于单中心23Na-MRI检测,尚需更大样本验证其预测价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Skin fibrosis is the predominant feature of SSc and arises from excessive extracellular matrix deposition. Glycosaminoglycans are macromolecules of the extracellular matrix, which facilitate Na + accumulation in the skin. We used 23 Na-MRI to quantify Na + in skin. We hypothesized that skin Na + might accumulate in SSc and might be a biomarker for skin fibrosis. METHODS: In this observational case-control study, skin Na + was determined by 23 Na-MRI using a Na + volume coil in 12 patients with diffuse cutaneous SSc and in 21 control subjects. We assessed skin fibrosis by the modified Rodnan skin score prior to 23 Na-MRI and on follow-up 12 months later. RESULTS: 23 Na-MRI demonstrated increased Na + in the fibrotic skin of SSc patients compared with skin from controls [mean ( s . d .): 27.2 (5.6) vs 21.4 (5.3) mmol/l, P < 0.01]. Na + content was higher in fibrotic than in non-fibrotic SSc skin [26.2 (4.8) vs 19.2 (3.4) mmol/l, P < 0.01]. Furthermore, skin Na + amount was correlated with changes in follow-up modified Rodnan skin score (R 2 = 0.68). CONCLUSIONS: 23 Na-MRI detected increased Na + in the fibrotic SSc skin; high Na + content was associated with progressive skin disease. Our findings provide the first evidence that 23 Na-MRI might be a promising tool to assess skin Na + and thereby predict progression of skin fibrosis in SSc.
引用
- Kopp C, Beyer C, Linz P, et al. Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging. Rheumatology (Oxford). 2017. PMID: 28013199. doi:10.1093/rheumatology/kew371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。